Search Results - "Voorman, Richard L."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Metabolic Aromatization of N-Alkyl-1,2,3,4-Tetrahydroquinoline Substructures to Quinolinium by Human Liver Microsomes and Horseradish Peroxidase by CHUNGANG GU, COLLINS, Roxane, HOLSWORTH, Daniel D, WALKER, Gregory S, VOORMAN, Richard L

    Published in Drug metabolism and disposition (01-12-2006)
    “…Metabolic aromatization of xenobiotics is an unusual reaction with some documented examples. For instance, the oxidation of…”
    Get full text
    Journal Article
  2. 2

    Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K) by Kikuchi, Ryota, Lao, Yanbin, Bow, Daniel A J, Chiou, William J, Andracki, Mark E, Carr, Robert A, Voorman, Richard L, De Morais, Sonia M

    Published in Journal of pharmaceutical sciences (01-12-2013)
    “…Veliparib (ABT-888) is largely eliminated as parent drug in human urine (70% of the dose). Renal unbound clearance exceeds glomerular filtration rate,…”
    Get more information
    Journal Article
  3. 3

    Parabens inhibit human skin estrogen sulfotransferase activity: Possible link to paraben estrogenic effects by Prusakiewicz, Jeffery J, Harville, Heather M, Zhang, Yanhua, Ackermann, Chrisita, Voorman, Richard L

    Published in Toxicology (Amsterdam) (11-04-2007)
    “…Abstract Parabens ( p -hydroxybenzoate esters) are a group of widely used preservatives in topically applied cosmetic and pharmaceutical products. Parabens…”
    Get full text
    Journal Article
  4. 4

    In vitro OATP1B1 and OATP1B3 inhibition is associated with observations of benign clinical unconjugated hyperbilirubinemia by Chiou, William J., de Morais, Sonia M., Kikuchi, Ryota, Voorman, Richard L., Li, Xiaofeng, Bow, Daniel A. J.

    Published in Xenobiotica (01-03-2014)
    “…Abstract 1.  Transient benign unconjugated hyperbilirubinemia has been observed clinically with several drugs including indinavir, cyclosporine, and rifamycin…”
    Get full text
    Journal Article
  5. 5

    Interaction of Delavirdine with Human Liver Microsomal Cytochrome P450: Inhibition of CYP2C9, CYP2C19, and CYP2D6 by VOORMAN, Richard L, PAYNE, N. Ann, WIENKERS, Larry C, HAUER, Michael J, SANDERS, Phillip E

    Published in Drug metabolism and disposition (01-01-2001)
    “…Delavirdine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, is metabolized primarily through desalkylation catalyzed by CYP3A4 and CYP2D6 and by…”
    Get full text
    Journal Article
  6. 6

    Development of in vitro methods to predict induction of CYP1A2 and CYP3A4 in humans by Grover, G Scott, Brayman, Timothy G, Voorman, Richard L, Ware, Joseph A

    Published in Assay and drug development technologies (01-12-2007)
    “…The important role of cytochrome P450 (CYP) drug-metabolizing enzymes has been studied for many years, and the potential liabilities of inducing these enzymes…”
    Get more information
    Journal Article
  7. 7

    Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A by VOORMAN, R. L, MAIO, S. M, HAUER, M. J, SANDERS, P. E, PAYNE, N. A, ACKLAND, M. J

    Published in Drug metabolism and disposition (01-07-1998)
    “…The metabolism of delavirdine was examined using liver microsomes from several species with the aim of comparing metabolite formation among species and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A by Voorman, R L, Maio, S M, Payne, N A, Zhao, Z, Koeplinger, K A, Wang, X

    “…Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic microsomal CYP3A and…”
    Get more information
    Journal Article
  11. 11

    Discovery, Synthesis, and Bioactivity of Bis(heteroaryl)piperazines. 1. A Novel Class of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors by Romero, Donna L, Morge, Raymond A, Biles, Carolyn, Berrios-Pena, Norman, May, Paul D, Palmer, John R, Johnson, Paul D, Smith, Herman W, Busso, Mariano, et. al

    Published in Journal of medicinal chemistry (01-04-1994)
    “…A variety of analogues of 1-[4-methoxy-3,5-dimethylbenzyl]-4-[3-(ethylamino)-2-pyridyl]piperazine hydrochloride (U-80493E) were synthesized and evaluated for…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Identification of Dioxin-Responsive Genes in Hep G2 Cells Using Differential mRNA Display RT–PCR by Wang, Xiaohong, Harris, Peter K.W., Ulrich, Roger G., Voorman, Richard L.

    “…Differential mRNA display RT–PCR (DD RT–PCR) offers a tool to identify genes which are regulated or responsive to certain receptors or chemicals such as dioxin…”
    Get full text
    Journal Article
  14. 14

    Absorption, Distribution, Metabolism, and Excretion of Atevirdine in the Rat by CHANG, M, SOOD, V. K, WILSON, G. J, KLOOSTERMAN, D. A, SANDERS, P. E, SCHUETTE, M. R, JUDY, R. W, VOORMAN, R. L, MAIO, S. M, SLATTER, J. G

    Published in Drug metabolism and disposition (01-10-1998)
    “…Atevirdine mesylate (U-87201E) is a highly specific nonnucleoside inhibitor of human immunodeficiency virus type 1 reverse transcriptase. The absorption,…”
    Get full text
    Journal Article
  15. 15